CN116159545A - Preparation method and application of magnetic molecular imprinting inverse opal photonic crystal microsphere - Google Patents
Preparation method and application of magnetic molecular imprinting inverse opal photonic crystal microsphere Download PDFInfo
- Publication number
- CN116159545A CN116159545A CN202310104352.0A CN202310104352A CN116159545A CN 116159545 A CN116159545 A CN 116159545A CN 202310104352 A CN202310104352 A CN 202310104352A CN 116159545 A CN116159545 A CN 116159545A
- Authority
- CN
- China
- Prior art keywords
- magnetic
- nanoparticles
- preparation
- photonic crystal
- inverse opal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 90
- 239000011022 opal Substances 0.000 title claims abstract description 48
- 239000004038 photonic crystal Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000002105 nanoparticle Substances 0.000 claims abstract description 71
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 claims abstract description 39
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000000178 monomer Substances 0.000 claims abstract description 33
- 230000001588 bifunctional effect Effects 0.000 claims abstract description 21
- 239000004793 Polystyrene Substances 0.000 claims abstract description 19
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 19
- 229920002223 polystyrene Polymers 0.000 claims abstract description 12
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims abstract description 11
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 35
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 26
- 238000000926 separation method Methods 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 239000002115 aflatoxin B1 Substances 0.000 claims description 13
- 239000000839 emulsion Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- 239000007810 chemical reaction solvent Substances 0.000 claims description 9
- 239000003999 initiator Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical group N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 7
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 7
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical group FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 6
- NXJCRELRQHZBQA-UHFFFAOYSA-N 5,7-dimethoxy-1-benzopyran-2-one Chemical compound C1=CC(=O)OC2=CC(OC)=CC(OC)=C21 NXJCRELRQHZBQA-UHFFFAOYSA-N 0.000 claims description 6
- 239000003431 cross linking reagent Substances 0.000 claims description 6
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 6
- 239000003053 toxin Substances 0.000 claims description 6
- 231100000765 toxin Toxicity 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000012986 modification Methods 0.000 claims description 5
- 230000004048 modification Effects 0.000 claims description 5
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical group CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims description 3
- 238000010907 mechanical stirring Methods 0.000 claims description 3
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 3
- 238000001338 self-assembly Methods 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 2
- 239000011261 inert gas Substances 0.000 claims description 2
- 239000007822 coupling agent Substances 0.000 claims 2
- 241000228212 Aspergillus Species 0.000 claims 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- JKKCSFJSULZNDN-UHFFFAOYSA-N gonyautoxin v Chemical compound N=C1NC(COC(=O)NS(O)(=O)=O)C2NC(=N)NC22C(O)(O)CCN21 JKKCSFJSULZNDN-UHFFFAOYSA-N 0.000 claims 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims 1
- 125000005395 methacrylic acid group Chemical group 0.000 claims 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims 1
- 229910000077 silane Inorganic materials 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 22
- 235000012239 silicon dioxide Nutrition 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 239000011258 core-shell material Substances 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 3
- 238000001179 sorption measurement Methods 0.000 description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 229930020125 aflatoxin-B1 Natural products 0.000 description 24
- 101100449517 Arabidopsis thaliana GRH1 gene Proteins 0.000 description 21
- 101100434479 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AFB1 gene Proteins 0.000 description 21
- 229920000642 polymer Polymers 0.000 description 20
- 238000000034 method Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 13
- 239000002245 particle Substances 0.000 description 11
- 239000000523 sample Substances 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 229910004298 SiO 2 Inorganic materials 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 7
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 7
- AFYCEAFSNDLKSX-UHFFFAOYSA-N coumarin 460 Chemical compound CC1=CC(=O)OC2=CC(N(CC)CC)=CC=C21 AFYCEAFSNDLKSX-UHFFFAOYSA-N 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000000944 Soxhlet extraction Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 239000004971 Cross linker Substances 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- 239000006087 Silane Coupling Agent Substances 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000000622 liquid--liquid extraction Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- HXVZGASCDAGAPS-UHFFFAOYSA-N 4-methylumbelliferyl acetate Chemical compound CC1=CC(=O)OC2=CC(OC(=O)C)=CC=C21 HXVZGASCDAGAPS-UHFFFAOYSA-N 0.000 description 2
- 102100034213 ATPase family protein 2 homolog Human genes 0.000 description 2
- 229930195730 Aflatoxin Natural products 0.000 description 2
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 101100434480 Arabidopsis thaliana AFB2 gene Proteins 0.000 description 2
- 101000780587 Homo sapiens ATPase family protein 2 homolog Proteins 0.000 description 2
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 2
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 229910018557 Si O Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000005409 aflatoxin Substances 0.000 description 2
- WWSYXEZEXMQWHT-WNWIJWBNSA-N aflatoxin B2 Chemical compound C=1([C@@H]2CCO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O WWSYXEZEXMQWHT-WNWIJWBNSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 230000005415 magnetization Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920000620 organic polymer Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- WMSKQFNEOMEGPQ-UHFFFAOYSA-N (4-methyl-2-oxochromen-3-yl) acetate Chemical compound C1=CC=C2OC(=O)C(OC(=O)C)=C(C)C2=C1 WMSKQFNEOMEGPQ-UHFFFAOYSA-N 0.000 description 1
- MGZOXZPZHVOXQB-UHFFFAOYSA-N 7-acetylumbelliferone Natural products C1=CC(=O)OC2=CC(OC(=O)C)=CC=C21 MGZOXZPZHVOXQB-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228230 Aspergillus parasiticus Species 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- ZCHPKWUIAASXPV-UHFFFAOYSA-N acetic acid;methanol Chemical compound OC.CC(O)=O ZCHPKWUIAASXPV-UHFFFAOYSA-N 0.000 description 1
- -1 acryl functional groups Chemical group 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229940056319 ferrosoferric oxide Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003837 high-temperature calcination Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000003361 porogen Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/268—Polymers created by use of a template, e.g. molecularly imprinted polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28009—Magnetic properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28016—Particle form
- B01J20/28021—Hollow particles, e.g. hollow spheres, microspheres or cenospheres
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/46—Materials comprising a mixture of inorganic and organic materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
技术领域Technical Field
本发明属于分离科学领域,具体涉及一种磁性分子印迹反蛋白石光子晶体微球的制备方法及其应用。The invention belongs to the field of separation science, and specifically relates to a preparation method and application of magnetic molecular imprinted inverse opal photonic crystal microspheres.
背景技术Background Art
食品安全问题一直以来是人们关注的重点。在食品的加工、运输、储藏和销售过程中会因为监管和操作的不规范而导致真菌污染。黄曲霉毒素是最常见的真菌毒素之一,是由黄曲霉菌和寄生曲菌产生的有毒次级代谢产物,可分为黄曲霉毒素B1、B2、G1、G2等,其中黄曲霉毒素B1毒性最高,也是肝癌的主要致病因素之一。它广泛存在于花生、玉米、大豆、小麦等粮食农产品中,由于其在脂肪中的高溶解性,在粮食被AFB1污染后,可通过食物链进人和动物体内,严重危害着人和动物的健康。因而一直以来都受到国际上的高度关注,并在1987年就被国际癌症研究机构认定为“1A”致癌物质。由于食品样品中黄曲霉毒素含量较低,且存在着基质干扰,因此需要高效和高选择性的样品前处理技术以实现目标物的萃取分析。Food safety has always been a focus of people's attention. In the process of food processing, transportation, storage and sales, fungal contamination may occur due to irregular supervision and operation. Aflatoxin is one of the most common mycotoxins. It is a toxic secondary metabolite produced by Aspergillus flavus and Aspergillus parasiticus. It can be divided into aflatoxin B1 , B2 , G1 , G2 , etc. Among them, aflatoxin B1 is the most toxic and is also one of the main pathogenic factors of liver cancer. It is widely present in grain and agricultural products such as peanuts, corn, soybeans, and wheat. Due to its high solubility in fat, after the grain is contaminated by AFB1 , it can enter the human and animal bodies through the food chain, seriously endangering the health of humans and animals. Therefore, it has always received high attention internationally and was identified as a "1A" carcinogen by the International Agency for Research on Cancer in 1987. Due to the low content of aflatoxin in food samples and the presence of matrix interference, efficient and highly selective sample pretreatment technology is required to achieve the extraction and analysis of the target.
目前对于待测样品中AFB1的前处理技术主要有液液萃取法(Liquid-liquidextraction,LLE)、免疫亲和柱(Immunoaffinity columns,IAC)和固相萃取法。但是液液萃取法往往是一个需要大量有机溶剂的繁琐过程,而免疫亲和柱制作成本高,对环境因素敏感,容易降解变性和不能重复使用而受到了一定的限制。固相萃取法又分为非选择性固相萃取法和选择性固相萃取法,前者选择性低,难以高效的用于复杂样品中痕量目标分析物的萃取和富集,后者可以通过选择不同的吸附材料来提高方法的有效性,其中,基于抗体的吸附材料特异性强,但抗体的获得费时且昂贵,因此,开发一种操作简单、特异性高、成本低的固相萃取前处理材料,用于分离富集实际样品中的AFB1是有必要的。At present, the main pretreatment technologies for AFB 1 in the sample to be tested are liquid-liquid extraction (LLE), immunoaffinity columns (IAC) and solid phase extraction. However, liquid-liquid extraction is often a cumbersome process that requires a large amount of organic solvents, while immunoaffinity columns are subject to certain limitations due to their high production cost, sensitivity to environmental factors, easy degradation and denaturation, and inability to be reused. Solid phase extraction is divided into non-selective solid phase extraction and selective solid phase extraction. The former has low selectivity and is difficult to be used efficiently for the extraction and enrichment of trace target analytes in complex samples. The latter can improve the effectiveness of the method by selecting different adsorption materials. Among them, antibody-based adsorption materials have strong specificity, but the acquisition of antibodies is time-consuming and expensive. Therefore, it is necessary to develop a solid phase extraction pretreatment material that is simple to operate, highly specific, and low-cost for separation and enrichment of AFB 1 in actual samples.
现有技术中公开了一种富集分离黄曲霉毒素B1的磁性光子晶体微球及其制备方法和应用(CN2021109175482),期制备的核壳型表面分子印迹磁性反蛋白石光子晶体微球,能够选择性萃取样品中的黄曲霉毒素B1,与修饰生物抗体的材料相比,能够极大提高材料的稳定性,降低材料制备成本。但是该核壳型表面分子印迹磁性反蛋白石光子晶体微球是通过在光子晶体微球表面采用单功能单体制备,因而只能提供单一的识别基团,导致其对目标分子的选择性较差,而且表面聚合物对反蛋白石微球的有序多孔结构造成了一定的破坏,影响了物质的传递,进而影响了分离富集时间。The prior art discloses a magnetic photonic crystal microsphere for enriching and separating aflatoxin B1 and its preparation method and application (CN2021109175482). The core-shell type surface molecular imprinted magnetic inverse opal photonic crystal microsphere prepared in the period can selectively extract aflatoxin B1 in the sample. Compared with the material modified with biological antibodies, it can greatly improve the stability of the material and reduce the material preparation cost. However, the core-shell type surface molecular imprinted magnetic inverse opal photonic crystal microsphere is prepared by using a monofunctional monomer on the surface of the photonic crystal microsphere, so it can only provide a single recognition group, resulting in poor selectivity for the target molecule, and the surface polymer causes certain damage to the ordered porous structure of the inverse opal microsphere, affecting the transfer of the substance, and thus affecting the separation and enrichment time.
发明内容Summary of the invention
发明目的:针对现有技术和材料存在的一些问题,本发明提供了一种磁性分子印迹反蛋白石光子晶体微球,本发明制备的用于分离富集黄曲霉毒素B1的磁性分子印迹反蛋白石光子晶体微球(MPCM@MIP)具有非常高的印迹因子,并且富集速度非常快,提高了特异性和富集速度。Purpose of the invention: In view of some problems existing in the prior art and materials, the present invention provides a magnetic molecular imprinted inverse opal photonic crystal microsphere. The magnetic molecular imprinted inverse opal photonic crystal microsphere (MPCM@MIP) prepared by the present invention for separating and enriching aflatoxin B1 has a very high imprinting factor and a very fast enrichment speed, thereby improving specificity and enrichment speed.
本发明还提供了所述的磁性分子印迹反蛋白石光子晶体微球及其应用。The invention also provides the magnetic molecular imprinted inverse opal photonic crystal microsphere and application thereof.
技术方案:为了实现上述目的,本发明所述一种磁性分子印迹反蛋白石光子晶体微球的制备方法,包括如下步骤:Technical solution: In order to achieve the above-mentioned purpose, the preparation method of a magnetic molecular imprinted inverse opal photonic crystal microsphere described in the present invention comprises the following steps:
(1)磁性四氧化三铁的表面修饰:调节正硅酸乙酯的溶液使其呈碱性,与四氧化三铁纳米粒子通过机械搅拌在水浴环境中进行二氧化硅包裹,再利用硅烷基偶联剂使其表面接枝双键的磁性纳米粒子;(1) Surface modification of magnetic ferroferric oxide: a solution of ethyl orthosilicate is adjusted to be alkaline, and the ferroferric oxide nanoparticles are coated with silica by mechanical stirring in a water bath environment, and then a silane coupling agent is used to graft double-bonded magnetic nanoparticles on the surface;
(2)磁性分子印迹纳米粒子的制备:取步骤(1)中修饰好的磁性纳米粒子,加入模板分子、双功能单体和交联剂以及反应溶剂后,进行反应;随后在惰性气体氛围下,加入引发剂,反应结束后在磁力作用下弃去反应剩余液体,产物洗脱模板分子后,获得磁性分子印迹纳米粒子。(2) Preparation of magnetic molecular imprinted nanoparticles: Take the magnetic nanoparticles modified in step (1), add template molecules, bifunctional monomers and cross-linking agents and reaction solvents, and then react; then add initiators under an inert gas atmosphere, and after the reaction is completed, discard the remaining reaction liquid under the action of magnetic force, and after the template molecules are eluted by the product, magnetic molecular imprinted nanoparticles are obtained.
(3)磁性分子印迹反蛋白石光子晶体微球的制备:取步骤(2)中制备好的磁性分子印迹纳米粒子,用纯水进行混合,再加入二氧化硅纳米粒子及聚苯乙烯纳米粒子乳液后,通过微流控自组装形成均匀微球,经固化干燥后,高温灼烧去除聚苯乙烯纳米粒子,获得反蛋白石结构磁性分子印迹光子晶体微球。(3) Preparation of magnetic molecular imprinted inverse opal photonic crystal microspheres: The magnetic molecular imprinted nanoparticles prepared in step (2) are mixed with pure water, and then silica nanoparticles and polystyrene nanoparticle emulsion are added to form uniform microspheres through microfluidic self-assembly. After curing and drying, the polystyrene nanoparticles are removed by high-temperature calcination to obtain magnetic molecular imprinted photonic crystal microspheres with an inverse opal structure.
本发明的微球是先合成能够特异性识别AFB1的纳米级磁性分子印迹纳米粒子,再利用该纳米粒子与聚苯乙烯和二氧化硅纳米粒子自组装成一种新型分子印迹反蛋白石微球。其中,所述纳米级磁性分子印迹纳米粒子是以四氧化三铁为基底,通过表面分子印迹策略利用双功能单体合成能够特异性识别黄曲霉毒素B1的分子印迹层。The microspheres of the present invention are synthesized by first synthesizing nanoscale magnetic molecular imprinted nanoparticles that can specifically recognize AFB 1 , and then using the nanoparticles to self-assemble with polystyrene and silicon dioxide nanoparticles into a novel molecular imprinted inverse opal microsphere. The nanoscale magnetic molecular imprinted nanoparticles are based on ferroferric oxide, and a molecular imprinting layer that can specifically recognize aflatoxin B 1 is synthesized by using a surface molecular imprinting strategy and a bifunctional monomer.
其中,步骤(1)中采用氨水调节正硅酸乙酯的溶液pH为8.0~9.0,机械搅拌转速为400-750r/min,恒温水浴为50℃,硅烷基偶联剂为3-(甲基丙烯酰氧)丙基三甲氧基硅烷。Wherein, in step (1), ammonia water is used to adjust the pH value of the tetraethyl orthosilicate solution to 8.0-9.0, the mechanical stirring speed is 400-750 r/min, the constant temperature water bath is 50° C., and the silane coupling agent is 3-(methacryloyloxy)propyltrimethoxysilane.
其中,步骤(2)中所述模板分子为5,7-二甲氧基香豆素,双功能单体分别为甲基丙烯酸和苯乙烯,交联剂为二甲基丙烯酸乙二醇酯,引发剂为偶氮二异丁腈,反应溶剂为乙腈或二甲基亚砜或N,N-二甲基甲酰胺。Wherein, the template molecule in step (2) is 5,7-dimethoxycoumarin, the bifunctional monomers are methacrylic acid and styrene, the crosslinking agent is ethylene glycol dimethacrylate, the initiator is azobisisobutyronitrile, and the reaction solvent is acetonitrile or dimethyl sulfoxide or N,N-dimethylformamide.
其中,步骤(2)中取步骤(1)中修饰好的磁性纳米粒子,加入模板分子、双功能单体和交联剂以及反应溶剂后,置于30-40℃反应1~2小时。In step (2), the magnetic nanoparticles modified in step (1) are added with template molecules, bifunctional monomers, crosslinking agents and reaction solvents, and then placed at 30-40° C. for reaction for 1 to 2 hours.
作为优选,所述步骤(2)中取步骤(1)中修饰好的磁性纳米粒子,加入模板分子、双功能单体和交联剂以及反应溶剂后,置于37℃反应1小时。其中,步骤(2)中在氮气气氛下,加入引发剂,置于60~80℃反应20~24h。Preferably, in step (2), the magnetic nanoparticles modified in step (1) are added with template molecules, bifunctional monomers, crosslinking agents and reaction solvents, and then reacted at 37°C for 1 hour. In step (2), an initiator is added under a nitrogen atmosphere, and the reaction is carried out at 60-80°C for 20-24 hours.
其中,步骤(3)中步骤所述磁性分子印迹纳米粒子水溶液的浓度为2~3%,二氧化硅纳米粒子乳液的浓度为15~25%,聚苯乙烯纳米粒子乳液的浓度为8~15%。Wherein, in step (3), the concentration of the magnetic molecular imprinted nanoparticle aqueous solution is 2-3%, the concentration of the silica nanoparticle emulsion is 15-25%, and the concentration of the polystyrene nanoparticle emulsion is 8-15%.
作为优选,所述磁性分子印迹纳米粒子水溶液的浓度为2.5%,二氧化硅纳米粒子乳液的浓度为20%,聚苯乙烯纳米粒子乳液的浓度为10%。上述浓度均为质量分数。Preferably, the concentration of the magnetic molecular imprinted nanoparticle aqueous solution is 2.5%, the concentration of the silicon dioxide nanoparticle emulsion is 20%, and the concentration of the polystyrene nanoparticle emulsion is 10%. The above concentrations are all mass fractions.
其中,步骤(3)中所述固化干燥温度为60~100℃,时间为16~24小时,高温灼烧温度为500~600℃,时间为2~3小时。Wherein, the curing and drying temperature in step (3) is 60-100° C., the time is 16-24 hours, and the high temperature burning temperature is 500-600° C., the time is 2-3 hours.
作为优选,所述固化干燥温度为60℃,时间为16小时,高温灼烧温度为550℃,时间为3小时。Preferably, the curing and drying temperature is 60° C., the time is 16 hours, and the high-temperature burning temperature is 550° C., the time is 3 hours.
作为优选,步骤(3)中采用索氏抽提法洗脱模板,索氏回流时,洗脱液为甲醇和乙酸的混合溶液(体积比为9:1)。Preferably, in step (3), the template is eluted by Soxhlet extraction, and during Soxhlet reflux, the eluent is a mixed solution of methanol and acetic acid (volume ratio is 9:1).
作为优选,所述四氧化三铁的粒径为10~50nm,二氧化硅纳米粒子的粒径为5~10nm,聚苯乙烯纳米粒子的粒径为250~300nm。Preferably, the particle size of the ferrosoferric oxide is 10-50 nm, the particle size of the silicon dioxide nanoparticles is 5-10 nm, and the particle size of the polystyrene nanoparticles is 250-300 nm.
本发明所述的制备方法所制备的磁性分子印迹反蛋白石光子晶体微球。本发明的磁性分子印迹反蛋白石光子晶体微球在合成过程中的仅需添加2mg具有特异性识别功能的磁性分子印迹纳米粒子即可合出60mg的反蛋白石微球,聚合物用量少(1/30),吸附量最高为5.2ug/mg,选择性系数在2.5~4.0之间。The magnetic molecular imprinted inverse opal photonic crystal microspheres prepared by the preparation method of the present invention. In the synthesis process of the magnetic molecular imprinted inverse opal photonic crystal microspheres of the present invention, only 2 mg of magnetic molecular imprinted nanoparticles with specific recognition function need to be added to synthesize 60 mg of inverse opal microspheres, the amount of polymer used is small (1/30), the maximum adsorption amount is 5.2 ug/mg, and the selectivity coefficient is between 2.5 and 4.0.
本发明所述的磁性分子印迹反蛋白石光子晶体微球在选择性高效分离富集黄曲霉毒素B1中的应用。The invention discloses an application of the magnetic molecular imprinted inverse opal photonic crystal microspheres in the selective and efficient separation and enrichment of aflatoxin B1 .
其中,所述微球可以通过外部磁场在较短时间内高特异性地完成目标毒素曲霉毒素B1的分离富集,时间不超过20分钟,印迹因子最高为8.0。The microspheres can separate and enrich the target toxin aflatoxin B1 with high specificity in a short time through an external magnetic field, the time does not exceed 20 minutes, and the maximum imprinting factor is 8.0.
本发明首先用二氧化硅对四氧化三铁纳米粒子进行包覆,然后在其表面修饰可聚合的官能团比如丙烯基,最后将其与分子预聚液反应,得到能够特异性识别AFB1的磁性分子印迹纳米粒子,在将其与二氧化硅纳米粒子及聚苯乙烯纳米粒子乳液混合经微流控系统组装成磁性分子印迹反蛋白石微球,用于实际样品中AFB1的分离富集。其中核壳型磁性分子印迹纳米粒子是通过表面分子印迹策略利用双功能单体合成能够特异性识别AFB1的分子印迹层,与传统的富集材料抗体和免疫亲和柱相比,本发明所述材料制备简单,成本低,易于保存和重复性利用。The present invention first coats ferroferric oxide nanoparticles with silicon dioxide, then modifies the surface of the nanoparticles with polymerizable functional groups such as propylene, and finally reacts the nanoparticles with molecular prepolymer solution to obtain magnetic molecular imprinted nanoparticles capable of specifically identifying AFB 1 , and then mixes the nanoparticles with silicon dioxide nanoparticles and polystyrene nanoparticle emulsions to form magnetic molecular imprinted inverse opal microspheres through a microfluidic system for separation and enrichment of AFB 1 in actual samples. The core-shell magnetic molecular imprinted nanoparticles are synthesized by using a surface molecular imprinting strategy and a bifunctional monomer to form a molecular imprinting layer capable of specifically identifying AFB 1. Compared with traditional enrichment materials such as antibodies and immunoaffinity columns, the material of the present invention is simple to prepare, low in cost, easy to store and reusable.
具体地,本发明将表面包裹二氧化硅并修饰丙烯基官能团的四氧化三铁与分子印迹预聚液混合,通过热引发聚合,获得能够特异性识别AFB1的磁性分子印迹纳米粒子,在通过微流控系统将其自组装成磁性分子印迹反蛋白石微球。其中所述微球利用的SiO2纳米颗粒粒径为5~10nm、PS纳米颗粒粒径为250~300nm、四氧化三铁的的粒径为10~50nm。Specifically, the present invention mixes ferroferric oxide with a surface coated with silicon dioxide and modified with acryl functional groups with a molecular imprinting prepolymer solution, obtains magnetic molecular imprinting nanoparticles capable of specifically recognizing AFB 1 through thermal initiation polymerization, and then self-assembles them into magnetic molecular imprinting inverse opal microspheres through a microfluidic system. The microspheres use SiO 2 nanoparticles with a particle size of 5 to 10 nm, PS nanoparticles with a particle size of 250 to 300 nm, and ferroferric oxide with a particle size of 10 to 50 nm.
设计机理:本发明磁性分子印迹反蛋白石光子晶体微球的选择性识别原理:通过正硅酸乙酯于磁性纳米粒子表面包裹二氧化硅并修饰丙烯基官能团后,以其为载体,以AFB1的结构类似物DMC、MUAC或MDAC为模板分子,与双功能单体之间会发生相互作用并形成模板-单体复合物,接着交联剂与双功能单体在引发剂的催化下会在磁性纳米粒子表面形成致密交联的聚合物膜,并使模板固定在其中。聚合结束后,通过索氏抽提将模板分子洗脱,从而在磁性纳米粒子表面留下具有与AFB1空间构型和作用位点相匹配的空腔,这些空腔对模板分子的结构类似物AFB1具有选择性识别能力,再将其与SiO2纳米颗粒、PS纳米乳液自组装为反蛋白石结构微球,其独特的多孔结构有利于提高吸附量和物质的传递,可对黄曲霉毒素B1进行高效选择性分离富集。Design mechanism: The selective recognition principle of the magnetic molecular imprinted inverse opal photonic crystal microspheres of the present invention: After the surface of magnetic nanoparticles is coated with silica and modified with propylene functional groups by tetraethyl orthosilicate, it is used as a carrier, and the structural analogues of AFB 1 , DMC, MUAC or MDAC, are used as template molecules, which interact with the bifunctional monomers and form a template-monomer complex. Then, the crosslinker and the bifunctional monomers form a densely crosslinked polymer film on the surface of the magnetic nanoparticles under the catalysis of the initiator, and the template is fixed therein. After the polymerization is completed, the template molecules are eluted by Soxhlet extraction, thereby leaving cavities on the surface of the magnetic nanoparticles that match the spatial configuration and action sites of AFB 1. These cavities have selective recognition ability for the structural analogues of the template molecules, AFB 1 , and then they are self-assembled with SiO 2 nanoparticles and PS nanoemulsions into inverse opal structure microspheres. Its unique porous structure is conducive to improving the adsorption amount and the transfer of substances, and can be used for efficient selective separation and enrichment of aflatoxin B 1 .
与现有技术CN2021109175482相比,其是通过将微球先制备出来,然后对其表面进行印迹聚合物的修饰,但在聚合前处理中,未对微球表面进行羟基化处理,因而会影响双键的接枝,进而影响到分子印迹聚合物的表面包裹,而在本发明中,首先利用二氧化硅对磁性纳米粒子进行表面包裹,提高其表面羟基量后再利用硅烷基偶联剂进行双键修饰,从而有效的改善了分子印迹聚合物嫁接。而且在聚合物合成过程中采用了双功能单体进行聚合,有利于提高分子识别性。在整个合成过程中,现有技术是先将微球制备出来,然后在微球表面做分子印迹,而本发明是将磁性分子印迹纳米粒子先合成出来作为合成磁性分子印迹光子晶体微球的组件,避免了在表面做分子印迹,因聚合物层对微球表面的包覆引起的有序多孔结构被破坏,反观以磁性分子印迹纳米粒子为合成分子印迹光子晶体微球的组件,完好的保存了反蛋白石微球特有的有序多孔结构,有利于加快物质传递,缩短分离富集时间。Compared with the prior art CN2021109175482, the microspheres are prepared first and then the surface is modified by the imprinted polymer. However, in the pre-polymerization treatment, the surface of the microspheres is not hydroxylated, which affects the grafting of double bonds and further affects the surface coating of the molecular imprinted polymer. In the present invention, the magnetic nanoparticles are first coated with silicon dioxide, and the amount of surface hydroxyl groups is increased and then the double bonds are modified with a silane coupling agent, thereby effectively improving the molecular imprinted polymer grafting. In addition, bifunctional monomers are used for polymerization during the polymer synthesis process, which is beneficial to improve molecular recognition. In the whole synthesis process, the prior art is to prepare microspheres first and then perform molecular imprinting on the surface of the microspheres, while the present invention is to first synthesize magnetic molecular imprinted nanoparticles as components for synthesizing magnetic molecular imprinted photonic crystal microspheres, thereby avoiding molecular imprinting on the surface and destroying the ordered porous structure caused by the coating of the microsphere surface by the polymer layer. On the other hand, the use of magnetic molecular imprinted nanoparticles as components for synthesizing molecular imprinted photonic crystal microspheres preserves the unique ordered porous structure of the inverse opal microspheres intactly, which is beneficial to accelerate material transfer and shorten separation and enrichment time.
本发明的磁性分子印迹反蛋白石光子晶体是以磁性分子印迹纳米粒子为吸附载体,其表面聚合的分子印迹层,能够选择性识别并富集分离实际样品中的AFB1,再通过微流控系统自装成反蛋白石光子晶体微球,其多孔有序结构能够加快物质的传递,增加富集量,而现有技术CN2021109175482通过表面修饰上分子印迹聚合物后,该多孔结构被聚合物层封堵,对反蛋白石微球的有序多孔结构造成了一定的破坏,影响了物质的传递,进而影响了分离富集时间。本发明的该微球利用表面印迹策略在磁性纳米粒子表面制备AFB1分子印迹层,有利于模板分子的洗脱和再吸附(其中洗脱是指制备材料过程中洗脱模板;再吸附是指在使用材料做测试或者应用过程中对模板分子或者目标物的吸附富集),克服了传统印迹法导致的印迹位点包埋过深导致吸附效率降低的缺陷,而且它独特的磁性能,赋予了微球磁性,无需过滤或离心,便于实现复杂基质中目标分子的快速分离。本发明制备的磁性分子印迹反蛋白石光子晶体微球,能够对实际样品中的AFB1进行快速选择性富集分离,而且操作简单快速,成本低,稳定性好,能够重复利用,是AFB1生物抗体的良好取代材料。The magnetic molecular imprinted inverse opal photonic crystal of the present invention uses magnetic molecular imprinted nanoparticles as adsorption carriers, and the molecular imprinted layer polymerized on its surface can selectively identify and enrich and separate AFB1 in actual samples, and then self-assemble into inverse opal photonic crystal microspheres through a microfluidic system. Its porous ordered structure can accelerate the transfer of substances and increase the enrichment amount. However, in the prior art CN2021109175482, after the molecular imprinted polymer is modified on the surface, the porous structure is blocked by the polymer layer, which causes certain damage to the ordered porous structure of the inverse opal microspheres, affects the transfer of substances, and further affects the separation and enrichment time. The microspheres of the present invention use a surface imprinting strategy to prepare an AFB1 molecular imprinting layer on the surface of magnetic nanoparticles, which is conducive to the elution and re-adsorption of template molecules (wherein elution refers to the elution of the template in the process of preparing the material; re-adsorption refers to the adsorption and enrichment of the template molecule or the target object in the process of using the material for testing or application), and overcome the defect of the traditional imprinting method that the imprinting site is embedded too deeply, resulting in reduced adsorption efficiency. In addition, its unique magnetic properties give the microspheres magnetism, and no filtration or centrifugation is required, which facilitates the rapid separation of target molecules in complex matrices. The magnetic molecular imprinting inverse opal photonic crystal microspheres prepared by the present invention can rapidly and selectively enrich and separate AFB1 in actual samples, and the operation is simple and fast, the cost is low, the stability is good, and it can be reused, and it is a good replacement material for AFB1 biological antibodies.
本发明通过在磁性纳米粒子表面进行二氧化硅包覆,从而提供大量的羟基以便于双键的接枝,进而有利于利用双功能单体制备能够高效萃取分离黄曲霉毒素B1分子印迹层,不同于单功能单体只能提供一种分子识别基团,双功能单体通过提供不同的识别基团进而提高分子聚合物的特异性;再利用微流控自装成反蛋白石结构光子晶体微球,不同于通过表面分子印迹技术在反蛋白石光子晶体微球表面修饰分子印迹层而导致微球表面的多孔结构被聚合物层包埋的缺陷,该方法制备的新型磁性分子印迹光子晶体微球是利用磁性分子印迹纳米粒子代替传统的四氧化三铁作为分子印迹反蛋白微球的合成组件,从而有效避免了后期表面修饰引发的堵塞问题,完美的保存了反蛋白微球的有序多孔结构,有利于加快物质的传递,极大的缩短富集时间,提高富集量,磁性纳米粒子可赋予物质磁性能,其上具有的分子印迹层具有分子筛作用,可以特异性富集、分离复杂样品的目标分子。The present invention coats the surface of magnetic nanoparticles with silicon dioxide, thereby providing a large number of hydroxyl groups for double bond grafting, thereby facilitating the use of bifunctional monomers to prepare a molecular imprinting layer capable of efficiently extracting and separating aflatoxin B1 . Unlike a monofunctional monomer that can only provide one molecular recognition group, the bifunctional monomer provides different recognition groups to improve the specificity of the molecular polymer; and then self-assembles into an inverse opal structure photonic crystal microsphere by microfluidics. Different from the defect that the molecular imprinting layer is modified on the surface of the inverse opal photonic crystal microsphere by the surface molecular imprinting technology, resulting in the porous structure on the surface of the microsphere being buried by the polymer layer, the novel magnetic molecular imprinting photonic crystal microsphere prepared by the method uses magnetic molecular imprinting nanoparticles instead of traditional ferroferric oxide as a synthetic component of the molecular imprinting inverse protein microsphere, thereby effectively avoiding the clogging problem caused by the later surface modification, perfectly preserving the ordered porous structure of the inverse protein microsphere, facilitating the transfer of substances, greatly shortening the enrichment time, and increasing the enrichment amount. The magnetic nanoparticles can give magnetic properties to substances, and the molecular imprinting layer thereon has a molecular sieve effect, and can specifically enrich and separate target molecules of complex samples.
有益效果:与现有技术相比,本发明具有如下优点:Beneficial effects: Compared with the prior art, the present invention has the following advantages:
(1)通过双功能单体合成了能够特异性识别AFB1的新型分子印迹聚合物,提高了目标毒素的富集性能。(1) A novel molecular imprinting polymer that can specifically recognize AFB1 was synthesized using bifunctional monomers, thereby improving the enrichment performance of the target toxin.
(2)本发明在磁性纳米粒子表面聚合印迹层,其独特的磁性能,易于通过外部磁场进行分离富集,无需过滤或离心等操作,省时省力。(2) The present invention polymerizes the imprinted layer on the surface of magnetic nanoparticles. Its unique magnetic properties make it easy to separate and enrich through an external magnetic field without the need for filtration or centrifugation, saving time and effort.
(3)本发明制备的磁性分子印迹纳米粒子整体粒径为纳米级,将其自组装至光子晶体内部,合成了新型磁性分子印迹反蛋白石光子晶体微球。(3) The overall particle size of the magnetic molecular imprinted nanoparticles prepared by the present invention is nanometer-scale, and they are self-assembled into the interior of photonic crystals to synthesize novel magnetic molecular imprinted inverse opal photonic crystal microspheres.
(4)本发明制备的磁性分子印迹反蛋白石光子晶体微球完好的保存了反蛋白微球的有序多孔结构,印迹因子高,加快了物质的传递,缩短富集时间。(4) The magnetic molecular imprinted inverse opal photonic crystal microspheres prepared by the present invention well preserve the ordered porous structure of the inverse protein microspheres, have a high imprinting factor, accelerate the transfer of substances, and shorten the enrichment time.
(5)本发明制备的磁性分子印迹反蛋白石光子晶体微球具有制备简单,稳定性好,富集分离效率高,特异性好和成本低等优点,可以进行工业化生产。(5) The magnetic molecular imprinted inverse opal photonic crystal microspheres prepared by the present invention have the advantages of simple preparation, good stability, high enrichment and separation efficiency, good specificity and low cost, and can be industrially produced.
(6)通过自组装技术制备而成的磁性分子印迹反蛋白石光子晶体微球,可通过调节加磁量实现不同环境下对于磁性能的要求,并且易于储存,可有效替代传统的固相萃取材料。(6) The magnetic molecular imprinted inverse opal photonic crystal microspheres prepared by self-assembly technology can meet the requirements of magnetic properties under different environments by adjusting the amount of magnetization. They are easy to store and can effectively replace traditional solid phase extraction materials.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为磁性分子印迹反蛋白石光子晶体微球的制备技术路线图;FIG1 is a technical roadmap for preparing magnetic molecularly imprinted inverse opal photonic crystal microspheres;
图2为磁性分子印迹纳米粒子改性聚合后的红外表征,;FIG2 is an infrared characterization of magnetic molecular imprinted nanoparticles after modification and polymerization;
图3为不同模板分子对磁性分子印迹纳米粒子吸附性能影响;FIG3 shows the effect of different template molecules on the adsorption performance of magnetic molecular imprinted nanoparticles;
图4为不同功能单体对磁性分子印迹纳米粒子吸附性能影响;FIG4 shows the effect of different functional monomers on the adsorption performance of magnetic molecular imprinted nanoparticles;
图5为不同加磁量对磁性分子印迹纳米粒子吸附性能影响;FIG5 shows the effect of different magnetization amounts on the adsorption performance of magnetic molecular imprinted nanoparticles;
图6为磁性分子印迹反蛋白石光子晶体微球的形貌表征;FIG6 is a morphological characterization of magnetic molecular imprinted inverse opal photonic crystal microspheres;
图7为磁性分子印迹反蛋白石光子晶体微球的吸附饱和曲线;FIG7 is an adsorption saturation curve of magnetic molecular imprinted inverse opal photonic crystal microspheres;
图8为磁性分子印迹反蛋白石光子晶体微球的吸附动力学;FIG8 shows the adsorption kinetics of magnetic molecularly imprinted inverse opal photonic crystal microspheres;
图9为磁性分子印迹反蛋白石光子晶体微球的吸附特异性测试。FIG. 9 is a test of adsorption specificity of magnetic molecular imprinted inverse opal photonic crystal microspheres.
具体实施方式DETAILED DESCRIPTION
实施例中所述实验方法,如无特殊说明,均为常规方法;所述试剂和材料,如无特殊说明,均可从商业途径获得。磁性分子印迹反蛋白石光子晶体微球的制备总体技术路线见图1。The experimental methods described in the examples are conventional methods unless otherwise specified; the reagents and materials described are commercially available unless otherwise specified. The overall technical route for the preparation of magnetic molecular imprinted inverse opal photonic crystal microspheres is shown in FIG1 .
其中,四氧化三铁(Fe3O4)分散液的粒径为10~50nm,二氧化硅(SiO2)纳米粒子的粒径为5~10nm。均购买于Sigma-Aldrich。The particle size of the Fe 3 O 4 dispersion is 10-50 nm, and the particle size of the SiO 2 nanoparticles is 5-10 nm. Both were purchased from Sigma-Aldrich.
聚苯乙烯纳米微球(PS)纳米粒子的粒径约为300nm,购于南京彩纳生物科技有限公司,CAS9006-53-6。The particle size of polystyrene nanospheres (PS) nanoparticles was about 300 nm and was purchased from Nanjing Caina Biotechnology Co., Ltd., CAS9006-53-6.
实施例1Example 1
1、磁性纳米粒子的表面修饰:1. Surface modification of magnetic nanoparticles:
(1)二氧化硅包覆:取1.5g Fe3O4分散液(1.5gFe3O4水分散液中含有375mg的Fe3O4)于1000mL三颈烧瓶中,加入100mL的0.1M HCL超声15min后,在外部磁场作用下超纯水洗涤至中性,加50mL超纯水、200mL乙醇超声15min使其均匀混合后,在50℃水浴锅中以650r/min的转速搅拌10min再加入2.5mL浓度为25%的氨水,搅拌30min使液体pH在8.0~9.0之间,每隔5min加入TEOS和乙醇的混合溶剂(1.2mL TEOS+8.8mL乙醇),每次1mL,分十次加完后50℃搅拌20h,反应完成后,用乙醇和超纯水交替洗涤数次至中性,真空干燥备用。(1) Silica coating: 1.5 g of Fe 3 O 4 dispersion (1.5 g of Fe 3 O 4 aqueous dispersion contains 375 mg of Fe 3 O 4 ) was placed in a 1000 mL three-necked flask, 100 mL of 0.1 M HCL was added and ultrasonicated for 15 min, then washed with ultrapure water under an external magnetic field until neutral, 50 mL of ultrapure water and 200 mL of ethanol were added and ultrasonicated for 15 min to make them uniformly mixed, then stirred at 650 r/min in a 50°C water bath for 10 min, then 2.5 mL of 25% ammonia water was added and stirred for 30 min until the pH value of the liquid was between 8.0 and 9.0, and a mixed solvent of TEOS and ethanol (1.2 mL TEOS + 8.8 mL ethanol) was added every 5 min, 1 mL each time, in ten times, and stirred at 50°C for 20 h. After the reaction was completed, the mixture was washed alternately with ethanol and ultrapure water for several times until neutral, and vacuum dried for use.
(2)表面接枝双键:取干燥后的磁性粒子400mg于250mL三颈烧瓶中,加入100mL甲醇溶液超声15min,待磁性纳米粒子混匀后通入氮气,在氮气氛围下滴加7.5mL 3-(甲基丙烯酰氧)丙基三甲氧基硅烷后超声10min后置于25℃恒温水浴中剧烈机械搅拌24h,反应完成后,用乙醇和超纯水交替洗涤数次至中性,真空烘干备用。(2) Surface grafting of double bonds: 400 mg of the dried magnetic particles were placed in a 250 mL three-necked flask, and 100 mL of methanol solution was added and ultrasonicated for 15 min. After the magnetic nanoparticles were mixed, nitrogen was introduced. 7.5 mL of 3-(methacryloyloxy)propyltrimethoxysilane was added dropwise under a nitrogen atmosphere, and ultrasonicated for 10 min. The mixture was placed in a 25°C constant temperature water bath and vigorously mechanically stirred for 24 h. After the reaction was completed, the mixture was washed alternately with ethanol and ultrapure water several times until neutral, and then vacuum dried for use.
实施例2Example 2
以实施例1中制备出的磁性纳米粒子为基底,合成磁性分子印迹纳米粒子,具体步骤如下:Using the magnetic nanoparticles prepared in Example 1 as a substrate, magnetic molecular imprinted nanoparticles were synthesized in the following specific steps:
1、分子印迹聚合:1. Molecular imprinting polymerization:
利用表面分子印迹技术,将30mg表面改性后的磁性纳米粒子置于离心管中,加入模板分子、双功能单体、交联剂并用致孔剂(即反应溶剂乙腈)定容至6mL,于37℃摇床反应1h,转速为200rpm。随后通氮气6min,再加入引发剂,用封口膜密封离心管后置于放入60℃、220rpm的摇床震荡反应24h。反应结束后,在磁铁的作用下弃去反应液体,获得有机聚合物层包被的磁性分子印迹纳米粒子(MMIPs)。Using the surface molecular imprinting technique, 30 mg of surface-modified magnetic nanoparticles were placed in a centrifuge tube, template molecules, bifunctional monomers, crosslinkers were added, and the volume was adjusted to 6 mL with a porogen (i.e., reaction solvent acetonitrile), and the reaction was carried out on a shaker at 37°C for 1 hour at a speed of 200 rpm. Then nitrogen was passed for 6 minutes, and then the initiator was added. The centrifuge tube was sealed with a sealing film and placed in a shaker at 60°C and 220 rpm for 24 hours. After the reaction, the reaction liquid was discarded under the action of a magnet to obtain magnetic molecular imprinted nanoparticles (MMIPs) coated with an organic polymer layer.
2、模板分子的去除:2. Removal of template molecules:
利用索氏抽提法,将步骤1的纳米粒子用滤纸包裹,放入虹吸管内,烧瓶中加入120mL甲醇-乙酸(9:1,v/v)混合液,索氏回流80℃洗脱12h后换成120mL纯甲醇以洗去乙酸,真空干燥即可得到磁性分子印迹纳米粒子,非印迹磁性分子印迹纳米粒子(MNIPs)的制备步骤同上步骤1和2,但不添加模板分子。Using the Soxhlet extraction method, the nanoparticles in
3、合成条件优化:3. Optimization of synthesis conditions:
按上述步骤1和2的方法考察不同的模板分子、功能单体以及加磁量。Different template molecules, functional monomers and magnetic addition amounts were investigated according to the methods in
(1)模板分子(1) Template molecule
取30mg实施例1中已经修饰双键的磁性纳米粒子于离心管内(实施例1的步骤2的终产物),向管中分别添加0.03mmol模板分子(5,7-二甲氧基香豆素(DMC)、7-乙酰氧基-4-甲基香豆素(MUAC)或7-二乙氨基-4-甲基香豆素(MDAC)),双功能单体甲基丙烯酸MAA0.3mmol、苯乙烯ST 0.015mmol和交联剂二甲基丙烯酸乙二醇酯EGDMA 0.75mmol并用乙腈定容至6mL,37℃摇床反应1h后,转速为200rpm。随后通氮气6min,加入引发剂偶氮二异丁腈AIBN0.014mmol,用封口膜密封离心管,最后放入60℃摇床220rpm震荡24h。反应完毕,用索氏提取法去除模板分子,最终可获得三种MMIPs。Take 30 mg of the magnetic nanoparticles modified with double bonds in Example 1 in a centrifuge tube (the final product of
制备的三种磁性分子印迹纳米粒子对相应模板分子的吸附性能如图3所示,以DMC、MUAC和MDAC三种模板合成的MIP对相应模板的印迹因子分别为:1.44、0.97、1.13(印迹因子为分子印迹聚合物对模板分子的吸附量与非分子印迹聚合物对模板分子的吸附量的比值);吸附量分别为1.53、1.18、1.28ug/mg,说明以DMC为模板合成的印迹材料对AFB1的特异性好,吸附能力强,所以后续实验选择DMC作为模板分子。其中吸附性能/吸附量参考实施例5,模板分子的吸附性能检测如下:将聚合物(三种MMIPs)与模板分子在吸附溶剂中混合,室温震荡过夜后,取上清液测试其中的模板分子浓度即吸附后溶液中的模板分子浓度,根据吸附前后模板分子浓度的差值计算聚合物的吸附量。The adsorption performance of the three prepared magnetic molecular imprinted nanoparticles on the corresponding template molecules is shown in Figure 3. The imprinting factors of the MIPs synthesized with three templates of DMC, MUAC and MDAC on the corresponding templates are respectively: 1.44, 0.97, 1.13 (imprinting factor is the ratio of the adsorption amount of the molecular imprinting polymer on the template molecule to the adsorption amount of the non-molecular imprinting polymer on the template molecule); the adsorption amounts are respectively 1.53, 1.18, 1.28ug/mg, indicating that the imprinting material synthesized with DMC as the template has good specificity for AFB1 and strong adsorption capacity, so DMC is selected as the template molecule in subsequent experiments. The adsorption performance/adsorption amount refers to Example 5, and the adsorption performance of the template molecule is detected as follows: the polymer (three MMIPs) and the template molecule are mixed in the adsorption solvent, and after shaking at room temperature overnight, the supernatant is taken to test the template molecule concentration therein, that is, the template molecule concentration in the solution after adsorption, and the adsorption amount of the polymer is calculated according to the difference between the template molecule concentration before and after adsorption.
(2)功能单体(2) Functional monomer
单体与模板的相互作用力大小决定着印迹材料对目标分子选择识别能力的强弱,因此选择合适的功能单体至关重要,按上述步骤(1)的方法,分别选取甲基丙烯酸(MAA)、4-乙烯基吡啶(4-VP)、苯乙烯(ST)和丙烯酰胺(AAm)作为单体与模板分子DMC进行结合反应制备出不同的磁性分子印迹纳米粒子,并对其模板分子进行吸附实验,结果见图4a),用MAA、4-VP、ST、AAm作为功能单体制备的MMIPs对DMC的吸附量分别为:1.53、0.51、3.34、0.16ug/mg;印迹因子分别为1.44、1.02、1.08和1,为了提高吸附量和选择性,使用ST和MAA作为双功能单体,并对其比例进行优化,结果如图4b,但当ST:MAA=1:2(摩尔比)时,对DMC吸附量为2.06ug/mg,印迹因子为1.62,其余印迹因子为1.34(ST:MAA=0:1)、1.09(ST:MAA=2:1)、1.21(ST:MAA=1:1)、1.08(ST:MAA=1:0),因此选择ST:MAA=1:2作为双功能单体。The interaction between the monomer and the template determines the strength of the imprinting material's ability to select and recognize the target molecule. Therefore, it is crucial to select a suitable functional monomer. According to the method in step (1) above, methyl methacrylate (MAA), 4-vinyl pyridine (4-VP), styrene (ST) and acrylamide (AAm) were selected as monomers to react with the template molecule DMC to prepare different magnetic molecular imprinted nanoparticles, and adsorption experiments were carried out on the template molecules. The results are shown in Figure 4a). The adsorption amounts of DMC by MMIPs prepared with MAA, 4-VP, ST and AAm as functional monomers are 1.53, 0.51, 3.34, and 0.63, respectively. 0.16ug/mg; the imprinting factors are 1.44, 1.02, 1.08 and 1 respectively. In order to improve the adsorption amount and selectivity, ST and MAA are used as bifunctional monomers, and their ratio is optimized. The result is shown in Figure 4b. However, when ST:MAA=1:2 (molar ratio), the adsorption amount of DMC is 2.06ug/mg, and the imprinting factor is 1.62. The other imprinting factors are 1.34 (ST:MAA=0:1), 1.09 (ST:MAA=2:1), 1.21 (ST:MAA=1:1), and 1.08 (ST:MAA=1:0). Therefore, ST:MAA=1:2 is selected as the bifunctional monomer.
此外,采用实施例2的方法,同时考察模板分子乙酰氧基-4-甲基香豆素(MUAC)或7-二乙氨基-4-甲基香豆素(MDAC)分别与单体4-乙烯基吡啶(4-VP)或者苯乙烯(ST)制备的磁性分子印迹聚合物其效果也均明显不如模板分子为DMC,双功能单体为ST:MAA=1:2制备的聚合物。In addition, the method of Example 2 was used to examine the magnetic molecular imprinting polymers prepared by using the template molecule acetoxy-4-methylcoumarin (MUAC) or 7-diethylamino-4-methylcoumarin (MDAC) and the monomers 4-vinylpyridine (4-VP) or styrene (ST). The effects were also significantly inferior to the polymers prepared by using the template molecule as DMC and the bifunctional monomer as ST:MAA=1:2.
(3)加磁量(3) Adding magnetism
作为基底材料的磁性纳米粒子,其含量一定程度上决定了表面分子印迹包裹是否均匀,因此选择合适的加磁量十分必要,按上述步骤(1)的方法,分别选择15mg、30mg、60mg的磁性纳米粒子,制备出三种不同的MMIPs,并对模板分子DMC进行吸附实验,结果如图5所示,加磁量分别为15mg、30mg、60mg的MMIPs对DMC的吸附量分别为:2.59、3.16、2.12ug/mg;印迹因子分别为1.2、1.53、1.49,说明加磁量为30mg时,所制备的聚合物吸附量和选择性相对较好,所以加磁量选择30mg。The content of magnetic nanoparticles as the substrate material determines to a certain extent whether the surface molecular imprinting coating is uniform. Therefore, it is necessary to select an appropriate magnetic addition amount. According to the method of step (1) above, 15 mg, 30 mg, and 60 mg of magnetic nanoparticles were selected to prepare three different MMIPs, and adsorption experiments were carried out on the template molecule DMC. The results are shown in Figure 5. The adsorption amounts of DMC by MMIPs with magnetic addition amounts of 15 mg, 30 mg, and 60 mg were 2.59, 3.16, and 2.12 ug/mg, respectively; the imprinting factors were 1.2, 1.53, and 1.49, respectively, indicating that when the magnetic addition amount was 30 mg, the adsorption amount and selectivity of the prepared polymer were relatively good, so the magnetic addition amount was selected to be 30 mg.
4、MMIPs形貌表征:4. MMIPs morphology characterization:
对上述制备的MMIPs(模板分子为DMC,功能单体为ST:MAA=1:2)进行红外光谱表征,见附图2。在465cm-1处有典型Si-O弯曲振动峰,805cm-1和1085cm-1分别为Si-O的对称和非对称拉伸,利用3-(甲基丙烯酰氧)丙基三甲氧基硅烷修饰Fe3O4-SiO2后,Fe3O4-SiO2-CH2=CH2的C=O基团在1720cm-1附近表现出弱振动,说明Fe3O4-SiO2表面成功接枝了双键官能团。1730cm-1附近出现了来自MAA(甲基丙烯酸)和EGDMA(二甲基丙烯酸乙二醇酯)的C=O基团的强特征峰,表明有机聚合物成功地附着在磁性纳米粒子表面。The MMIPs prepared above (template molecule is DMC, functional monomer is ST:MAA=1:2) were characterized by infrared spectroscopy, see Figure 2. There is a typical Si-O bending vibration peak at 465cm -1 , 805cm- 1 and 1085cm -1 are symmetric and asymmetric stretching of Si-O respectively. After Fe 3 O 4 -SiO 2 was modified with 3-(methacryloyloxy)propyltrimethoxysilane, the C=O group of Fe 3 O 4 -SiO 2 -CH 2 =CH 2 showed weak vibration near 1720cm -1 , indicating that the double bond functional group was successfully grafted on the surface of Fe 3 O 4 -SiO 2. Strong characteristic peaks of C=O groups from MAA (methacrylic acid) and EGDMA (ethylene glycol dimethacrylate) appeared near 1730cm -1 , indicating that the organic polymer was successfully attached to the surface of magnetic nanoparticles.
实施例3Example 3
实施例3与实施例2制备方法相同,不同之处在于:反应溶剂为二甲基亚砜或N,N-二甲基甲酰胺,最后放入60℃、220rpm的摇床震荡24h。The preparation method of Example 3 is the same as that of Example 2, except that the reaction solvent is dimethyl sulfoxide or N,N-dimethylformamide, and the mixture is finally shaken at 60° C. and 220 rpm for 24 hours.
实施例4Example 4
1、磁性分子印迹反蛋白石光子晶体微球的制备:1. Preparation of magnetic molecular imprinted inverse opal photonic crystal microspheres:
采用实施例2中最优的磁性分子印迹纳米粒子,取终浓度(质量分数)20%的二氧化硅纳米溶液、10%的PS纳米溶液以及2.5%的磁性分子印迹纳米粒子水溶液置于离心管中,超声混匀为均匀乳液,转移到5mL注射器,另一个大的50mL注射器内装有甲基硅油。将两个注射器分别固定在恒流微流泵上,油相微流控流速10mL/h,乳相流速5mL/h。利用油包水的原理,甲基硅油将乳液截断成一颗颗微米级的液滴并收集于装有甲基硅油的塑料培养皿中。之后将培养皿放入60℃鼓风干燥箱恒温干燥,将液滴内的水分烘干后,分别用正己烷、无水乙醇清洗3至4遍,待乙醇挥发后转移至管式炉中,缓慢程序升温至550℃煅烧3h,以除去模板剂微球(去除PS微球),即可得磁性分子印迹反蛋白石光子晶体微球(MPCM@MIP)。其中,原始乳液(20%的二氧化硅纳米溶液、10%的PS纳米溶液以及2.5%的磁性分子印迹纳米粒子水溶液)中MMIPs(或MNIPs):SiO2体积比为1:3,SiO2:PS体积比为1:8,并利用金相显微镜和扫描电镜对其进行表征,见附图6,其中,图6a表明以修饰分子印迹聚合的磁性纳米粒子作为合成反蛋白石微球的组件所制备而成的微球具有良好的磁性能,图6b为磁性分子印迹反蛋白石光子晶体微球的金相显微镜图,其中心具有明显的亮点,表明微球表面结构规整,具有反蛋白石的一般特性,图6c和图6d分别为微球在500X和5000X倍镜下的SEM图,其表明了所制备的磁性分子印迹反蛋白石微球整体为规则的球形,其表面的具有明显的有序多孔结构,通过对比CN2021109175482图2d的反蛋白石微球的表征图可以看出其表面的多孔结构没有被破坏,现有技术CN2021109175482通过表面修饰上分子印迹聚合物后,该多孔结构被聚合物层封堵(图6f),对反蛋白石微球的有序多孔结构造成了一定的破坏,影响了物质的传递,进而影响了分离富集时间。The optimal magnetic molecular imprinted nanoparticles in Example 2 were used, and a final concentration (mass fraction) of 20% of a silicon dioxide nano solution, 10% of a PS nano solution, and 2.5% of a magnetic molecular imprinted nanoparticle aqueous solution were placed in a centrifuge tube, ultrasonically mixed to form a uniform emulsion, and transferred to a 5 mL syringe. Another large 50 mL syringe was filled with methyl silicone oil. The two syringes were fixed on a constant current microfluidic pump, respectively, with an oil phase microfluidic flow rate of 10 mL/h and an emulsion phase flow rate of 5 mL/h. Using the principle of water-in-oil, the methyl silicone oil cut the emulsion into micron-sized droplets and collected them in a plastic culture dish containing methyl silicone oil. Then, the culture dish was placed in a 60°C forced air drying oven to dry the water in the droplets, and then washed with n-hexane and anhydrous ethanol for 3 to 4 times, and after the ethanol evaporated, it was transferred to a tube furnace and slowly heated to 550°C for calcination for 3 hours to remove the template microspheres (PS microspheres), and magnetic molecular imprinted inverse opal photonic crystal microspheres (MPCM@MIP) were obtained. Among them, the volume ratio of MMIPs (or MNIPs): SiO 2 in the original emulsion (20% silica nano solution, 10% PS nano solution and 2.5% magnetic molecular imprinted nanoparticle aqueous solution) was 1:3, and the SiO 2 :PS volume ratio is 1:8, and it is characterized by metallographic microscope and scanning electron microscope, see Figure 6, wherein Figure 6a shows that the microspheres prepared by using modified molecular imprinting polymerized magnetic nanoparticles as components for synthesizing inverse opal microspheres have good magnetic properties, Figure 6b is a metallographic microscope image of magnetic molecular imprinting inverse opal photonic crystal microspheres, with obvious bright spots in the center, indicating that the surface structure of the microspheres is regular and has the general characteristics of inverse opal, and Figures 6c and 6d are SEM images of the microspheres under 500X and 5000X magnifications, respectively, which show The prepared magnetic molecularly imprinted inverse opal microspheres are regular spherical as a whole, and their surface has an obvious ordered porous structure. By comparing the characterization diagram of the inverse opal microspheres in Figure 2d of CN2021109175482, it can be seen that the porous structure on its surface is not destroyed. In the prior art CN2021109175482, after the surface is modified with molecular imprinting polymer, the porous structure is blocked by the polymer layer (Figure 6f), which causes certain damage to the ordered porous structure of the inverse opal microspheres, affects the transfer of substances, and thus affects the separation and enrichment time.
实施例5Example 5
以实施例4制备的MPCM@MIP为材料。考察分析其吸附性能。The MPCM@MIP prepared in Example 4 was used as the material, and its adsorption performance was investigated and analyzed.
分别取三份实施例4制备的4mg微球于1000uL的5~50000ng/mL不同浓度的AFB1溶液中测定MPCM@MIP和MPCM@NIP(实施例4中用不添加模板分子非印迹磁性纳米粒子制备而成的微球)对黄曲霉毒素B1的富集能力,结果见图7,因为MPCM@MIP是由表面形成了能够特异性识别AFB1的印迹空腔的MMIPs制备而成,所以MPCM@MIP比MPCM@NIP能够分离富集到更多的AFB1。随着AFB1浓度的增加,MPCM@MIP的吸附量也逐渐增加,其印迹因子最大为8.0。Three 4 mg microspheres prepared in Example 4 were taken and placed in 1000 uL of 5 to 50000 ng/mL AFB1 solutions to determine the enrichment capacity of MPCM@MIP and MPCM@NIP (microspheres prepared by non-imprinted magnetic nanoparticles without adding template molecules in Example 4) for aflatoxin B1. The results are shown in Figure 7. Because MPCM@MIP is prepared by MMIPs with imprinted cavities on the surface that can specifically recognize AFB1, MPCM@MIP can separate and enrich more AFB1 than MPCM@NIP. As the concentration of AFB1 increases, the adsorption amount of MPCM@MIP also gradually increases, and its maximum imprinting factor is 8.0.
以1000ng/mL的AFB1测定MPCM@MIP和MPCM@NIP的吸附饱和速率,结果见图8,在这个浓度下最高的印迹因子为1.74,因为MMIPs为表面分子印迹聚合物,其结合位点暴露在粒子表面,能够实现快速对目标物质进行分离富集,而MPCM的有序多孔结构也促进了目标分子的传递,所以MPCM@MIP对AFB1能够快速进行富集,所需饱和富集时间为20min。通过对比CN2021109175482中实施例3最优条件制备的MIOPCM@MIP的孔隙率和比表面积如图6h,分别为6.7nm和60m2/g,可以发现,本发明中实施例4制备的MPCM@MIP的孔隙率和比表面积(图6g)为17.3nm和159m2/g,分别为CN2021109175482的2.6倍和2.7倍,比表面积越大,越有利于微球与目标分子接触,孔隙率越大,越有利于物质的传递,因而在相同的条件下本发明富集速度约为CN2021109175482的7倍,有效的缩短了富集时间。The adsorption saturation rate of MPCM@MIP and MPCM@NIP was measured with 1000 ng/mL AFB1. The results are shown in Figure 8. At this concentration, the highest imprinting factor was 1.74. Because MMIPs are surface molecular imprinting polymers, their binding sites are exposed on the particle surface, which can achieve rapid separation and enrichment of target substances. The ordered porous structure of MPCM also promotes the transfer of target molecules. Therefore, MPCM@MIP can quickly enrich AFB1, and the required saturation enrichment time is 20 min. By comparing the porosity and specific surface area of MIOPCM@MIP prepared under the optimal conditions of Example 3 in CN2021109175482 as shown in Figure 6h, which are 6.7 nm and 60 m 2 /g, respectively, it can be found that the porosity and specific surface area of MPCM@MIP prepared in Example 4 of the present invention (Figure 6g) are 17.3 nm and 159 m 2 /g, which are 2.6 times and 2.7 times that of CN2021109175482, respectively. The larger the specific surface area, the more conducive it is to the contact between the microspheres and the target molecules, and the larger the porosity, the more conducive it is to the transfer of substances. Therefore, under the same conditions, the enrichment rate of the present invention is about 7 times that of CN2021109175482, which effectively shortens the enrichment time.
实施例6Example 6
以实施例4制备的MPCM@MIP为材料,考察分析其特异性。The MPCM@MIP prepared in Example 4 was used as the material to investigate and analyze its specificity.
取三份实施例4制备的4mg微球加入2mL离心管中,分别加入1000uL 1000ng/mLAFB1、AFB2、AFG2、OTA、ZEN,200rpm的摇床在室温下震荡4h进行吸附实验。吸附结束后利用磁铁无需离心即可取出吸附上清液,上清液使用HPLC系统检测。结果如图9所示,MPCM@MIP对AFB1及其结构类似物AFB2和AFG2具有较好的识别能力,与OTA和ZEN相比,MPCM@MIP对AFB1的结合选择性更高,其印迹因子为1.73,选择性系数为2.62和3.69。相较于CN2021109175482(实施例5),该印迹因子增加了0.26,这主要是因为在合成过程中,磁性分子印迹聚合物纳米粒子加入量较低(每60mg的光子晶体微球仅含有2mg左右的磁性分子印迹纳米粒子),整体加入量通过质量换算可转换为每4mg的微球中仅含有0.13mg能够特异性识别AFB1的磁性分子印迹聚合物纳米粒子,而少量的纳米粒子便表现出较好的选择性。相较于CN2021109175482的每mL待测样品中使用2mg分子印迹微球(专利CN2021109175482通过在微球表面制备分子印迹聚合物,因此整体都有识别位点,是纯粹的分子印迹光子晶体微球,而本发明是先合出磁性分子印迹纳米粒子再将其组装进微球中,整体的识别位点只有组装进微球内部的磁性纳米粒子才有),本发明中具有识别性的分子印迹聚合物只用了0.13mg,明显低于上述专利,本发明单位质量内的具有特异性识别AFB1的聚合物具有更加明显的选择性。Take three portions of 4 mg microspheres prepared in Example 4 and add them to a 2 mL centrifuge tube, add 1000
实施例7Example 7
分离富集实际样品中的黄曲霉毒素B1,并联合HPLC进行定量分析。Aflatoxin B1 in actual samples was separated and enriched, and quantitative analysis was performed in combination with HPLC.
(1)制备加标样品(1) Preparation of spiked samples
选择玉米、小麦和大米作为真实样品。分别称取5g样品各四份于50mL离心管中,用甲醇稀释AFB1原液(2mg/mL),将其稀释到1000ng/mL。分别取0mL、0.125mL、0.25mL、1.25mL加入到称好的样品试管中,并定容到10mL,摇晃使样品与毒素均匀混合,置于通风橱中静置过夜,待甲醇挥发。向甲醇挥发完的样品中加入0.5g氯化钠和25mL甲醇和水的混合溶液(V/V=8:2),均质机中均质5min,之后超声30min提取毒素。提取完全后,用定性滤纸和0.22um滤头进行多次过滤后置于-20℃冰箱储藏。Corn, wheat and rice were selected as real samples. Weigh 5g of sample in four portions in 50mL centrifuge tubes, dilute AFB 1 stock solution (2mg/mL) with methanol to 1000ng/mL. Take 0mL, 0.125mL, 0.25mL and 1.25mL respectively and add them to the weighed sample tubes, and dilute to 10mL. Shake to mix the sample and toxin evenly, place in a fume hood and let stand overnight until the methanol evaporates. Add 0.5g of sodium chloride and 25mL of a mixed solution of methanol and water (V/V=8:2) to the sample after methanol evaporates, homogenize in a homogenizer for 5min, and then extract the toxin by ultrasound for 30min. After complete extraction, filter several times with qualitative filter paper and a 0.22um filter head and store in a -20℃ refrigerator.
取适量过滤后的样品溶液干燥后,加入等量的甲醇和水的混合液(V/V=1:1),配成浓度为0ng/mL,25ng/kg,50ng/kg,250ng/kg的实际样品溶液。Take an appropriate amount of filtered sample solution and dry it, then add an equal amount of a mixture of methanol and water (V/V=1:1) to prepare actual sample solutions with concentrations of 0 ng/mL, 25 ng/kg, 50 ng/kg, and 250 ng/kg.
(7)毒素萃取富集(7) Toxin extraction and enrichment
称取4mg的MPCM@MIP加入到1mL的上述实际样品溶液中,在室温下以200rpm震荡4h后,在磁铁作用下弃去上清液。最后,用甲醇和乙酸的混合溶液(V/V=9:1)洗脱吸附的AFB1,收集洗脱液。Weigh 4 mg of MPCM@MIP and add it to 1 mL of the actual sample solution. After shaking at 200 rpm for 4 h at room temperature, discard the supernatant under the action of a magnet. Finally, elute the adsorbed AFB1 with a mixed solution of methanol and acetic acid (V/V=9:1), and collect the eluate.
(3)HPLC定量分析黄曲霉毒素B1 (3) HPLC quantitative analysis of aflatoxin B1
首先,将洗脱液置于60℃烘箱中干燥,待液体挥发干后加入300μL三氟乙酸并衍生15分钟;然后用氮气吹干样品后,用200μL流动相进行复溶(甲醇/水=1/1,v/v)。样品在进行液相色谱检测前,用孔径为0.2μm的过滤器过滤。HPLC分析条件:C18 Agilent XDB(4.6×250毫米,5μm);甲醇/水(45/55,v/v)为流动相,流速1.0mL/min;荧光检测器,激发/发射波长为365/435nm;进样量20μL;柱温30℃。First, the eluent was placed in a 60°C oven to dry, and after the liquid evaporated, 300 μL of trifluoroacetic acid was added and derivatized for 15 minutes; then the sample was blown dry with nitrogen and reconstituted with 200 μL of mobile phase (methanol/water = 1/1, v/v). Before the sample was tested by liquid chromatography, it was filtered with a filter with a pore size of 0.2 μm. HPLC analysis conditions: C18 Agilent XDB (4.6×250 mm, 5 μm); methanol/water (45/55, v/v) as mobile phase, flow rate 1.0 mL/min; fluorescence detector, excitation/emission wavelength 365/435 nm;
(4)加标回收率结果(4) Spike recovery results
通过测定加标回收率,进一步评价了上述所建立固相萃取联合HPLC定量分析实际样品中黄曲霉毒素B1的方法。如表1所示,在玉米、小麦和大米样品中,AFB1的加标回收率分别为78.57%-91.94%、92.85%-105.07%和85.72%-98.39%,表明MPCM@MIP能有效地从实际样品中捕获AFB1,具有较高的准确度和特异性。The above-mentioned solid phase extraction combined with HPLC quantitative analysis of aflatoxin B1 in real samples was further evaluated by measuring the spike recovery rate. As shown in Table 1, the spike recovery rates of AFB1 in corn, wheat and rice samples were 78.57%-91.94%, 92.85%-105.07% and 85.72%-98.39%, respectively, indicating that MPCM@MIP can effectively capture AFB1 from real samples with high accuracy and specificity.
表1.黄曲霉毒素B1的加标回收率Table 1. Spiked recovery of aflatoxin B 1
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310104352.0A CN116159545A (en) | 2023-02-08 | 2023-02-08 | Preparation method and application of magnetic molecular imprinting inverse opal photonic crystal microsphere |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310104352.0A CN116159545A (en) | 2023-02-08 | 2023-02-08 | Preparation method and application of magnetic molecular imprinting inverse opal photonic crystal microsphere |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116159545A true CN116159545A (en) | 2023-05-26 |
Family
ID=86414337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310104352.0A Pending CN116159545A (en) | 2023-02-08 | 2023-02-08 | Preparation method and application of magnetic molecular imprinting inverse opal photonic crystal microsphere |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116159545A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190329221A1 (en) * | 2018-07-25 | 2019-10-31 | Jiangnan University | Synthesis and application of A Nanomaterial for Removal of Patulin |
CN110790933A (en) * | 2019-10-31 | 2020-02-14 | 中国药科大学 | Patulin magnetic molecularly imprinted polymer and preparation method and application thereof |
CN113670700A (en) * | 2021-08-10 | 2021-11-19 | 南京师范大学 | Aspergillus flavus enrichment and separation methodToxin B1Magnetic photonic crystal microsphere and preparation method and application thereof |
-
2023
- 2023-02-08 CN CN202310104352.0A patent/CN116159545A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190329221A1 (en) * | 2018-07-25 | 2019-10-31 | Jiangnan University | Synthesis and application of A Nanomaterial for Removal of Patulin |
CN110790933A (en) * | 2019-10-31 | 2020-02-14 | 中国药科大学 | Patulin magnetic molecularly imprinted polymer and preparation method and application thereof |
CN113670700A (en) * | 2021-08-10 | 2021-11-19 | 南京师范大学 | Aspergillus flavus enrichment and separation methodToxin B1Magnetic photonic crystal microsphere and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
CHAOFAN RUI: "Selective extraction and enrichment of aflatoxins from food samples bymesoporous silica FDU-12 supported aflatoxins imprinted polymers based on surface molecularly imprinting technique", TALANTA, vol. 201, 15 April 2019 (2019-04-15), pages 343 - 349 * |
CHENGXIN LUANA 等: "Responsive photonic encoded breathing microbeads basedmicrofluidic chip for multiplex fluorescent immunoassay", SENSORS AND ACTUATORS B: CHEMICAL, vol. 242, 15 September 2016 (2016-09-15), pages 1259 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Design and preparation of self-driven BSA surface imprinted tubular carbon nanofibers and their specific adsorption performance | |
CN110204735B (en) | Preparation method and application of a magnetic core-hollow porous molecularly imprinted polymer satellite assembly of macrolide antibiotics | |
Dai et al. | Preparation of molecularly imprinted nanoparticles with superparamagnetic susceptibility through atom transfer radical emulsion polymerization for the selective recognition of tetracycline from aqueous medium | |
Yavuz et al. | Synthesis of cholesterol imprinted polymeric particles | |
CN103506093B (en) | Magnetic dual-template protein molecule imprinted nano particle and preparation method thereof | |
CN103497276B (en) | A kind of preparation method and application of carbon nanotube-based magnetic organic phosphorous molecule imprinted polymer | |
CN104072678B (en) | Polymer microsphere, preparation and applications thereof | |
CN109078614B (en) | A kind of preparation method and application of dendritic boronic acid-based glycoprotein molecular surface imprinted polymer | |
CN113670700B (en) | Enrichment and separation of aflatoxin B1Magnetic photonic crystal microsphere of (2), preparation method and application thereof | |
WO2006123686A1 (en) | Support polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same | |
CN111151227A (en) | Semi-molecular imprinting material and preparation method and application thereof | |
CN105693960B (en) | A kind of preparation method of glutamic acid molecular imprinted polymer on surface silica gel microball | |
Jiang et al. | Nanoparticle-supported temperature responsive polymer brushes for affinity separation of histidine-tagged recombinant proteins | |
Lu et al. | Preparation and recognition of surface molecularly imprinted core–shell microbeads for protein in aqueous solutions | |
Garcia et al. | “On-off” switchable tool for food sample preparation: merging molecularly imprinting technology with stimuli-responsive blocks. Current status, challenges and highlighted applications | |
CN103301820B (en) | Core-shell type Rhodamine B molecular imprinting solid-phase extraction magnetic material, and preparation method and application thereof | |
CN110361462B (en) | Molecularly imprinted tube tip micro-extraction head and preparation method thereof | |
CN106512958B (en) | A kind of preparation method and application of aptamer modified chitosan nano fiber | |
CN113893833B (en) | Preparation method and application of molecular imprinting composite two-dimensional material for high-throughput identification of aflatoxin | |
CN116159545A (en) | Preparation method and application of magnetic molecular imprinting inverse opal photonic crystal microsphere | |
CN110845677B (en) | Dinotefuran molecularly imprinted material and application | |
CN102702565B (en) | Preparation method and application of indole acetic acid (IAA) molecularly imprinted polymer (MIP) | |
Li et al. | Preparation and characterization of hydrophilic molecularly imprinted microspheres for difenoconazole | |
CN114849672B (en) | A flavonoid magnetic recognition material and its preparation method and application in extracting flavonoids from Chinese herbal medicines | |
Huang et al. | Fabrication of a wood-based molecularly imprinted composite with pH/temperature-response for specific recognition of OVA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |